Article content

TORONTO — It’s being touted as the next new miracle ingredient for everything from pet treats to anti-aging face creams and elixirs that can help an athlete’s aching body recover faster.

But that’s not the only reason that cannabidiol or CBD, a compound derived from cannabis that doesn’t get people stoned, is being eyed by companies of all stripes including beverage giant Coca-Cola.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Why companies are eyeing the cannabis compound that doesn't get you high Back to video

Regulations and attitudes are warming up to it and the potential for CBD-infused products to be available on grocery or pharmacy shelves — instead of in tightly-regulated pot shops — in the not-so-distant future.

Including in Canada down the road, says Trina Fraser, an Ottawa-based lawyer who advises the cannabis industry.

Globally, the market for CBD could be “massive,” she said.

“Think about cosmetics, and skin creams, and arthritic topical creams, and all sorts of types of products that you would go to a drug store to buy that could have these potentially therapeutic effects from CBD… That’s certainly not unrealistic, and I think in fact, odds are, we will be there (in Canada). I hope, within the next five years.”